鶹ýӰ

Clinical Focus

Biosimilars

More in Biosimilars

FDA Committee Backs Rituximab Biosimilar for Lymphoma

Unanimous approval recommendation for CT-P10 in NHL

Oct 10, 2018
image
Neulasta Biosimilar OK'd

First copycat for blockbuster white cell booster

Jun 04, 2018
image

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis